We are live on
!
Find out more
DC
Decheng Capital Portfolio holdings
AUM
$661M
1-Year Est. Return
299.97%
This Fund
S&P 500
This Quarter
Est. Return
+11.95%
1 Year Est. Return
+299.97%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$422M
AUM Growth
+$95.9M
(+29%)
Cap. Flow
+$72.2M
Cap. Flow
% of AUM
17.11%
Top 10 Holdings %
Top 10 Hldgs %
87.52%
Holding
26
New
2
Increased
10
Reduced
2
Closed
–
Top Buys
| 1 |
Nuvation Bio
NUVB
|
+$58M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
+$5.59M |
| 3 |
NewAmsterdam Pharma
NAMS
|
+$3.29M |
| 4 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
+$1.94M |
| 5 |
ACLX
Arcellx
ACLX
|
+$1.33M |
Top Sells
| 1 |
Illumina
ILMN
|
+$1.73M |
| 2 |
GRAL
GRAIL Inc
GRAL
|
+$128K |
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CG Oncology
CGON
$6.44B
| $207M | 48.96% |
5,478,810
+20,000
| +0.4% | +$701K |
|
|
2
Nuvation Bio
NUVB
$2.05B
| $59.4M | 14.08% |
25,954,439
+19,004,200
| +273% | +$58M |
|
|
3
Phathom Pharmaceuticals
PHAT
$881M
| $22.6M | 5.35% |
1,250,000
+400,000
| +47% | +$5.59M |
|
4
Arcus Biosciences
RCUS
$3.52B
| $13.3M | 3.15% |
869,790
| – | – |
|
5
Krystal Biotech
KRYS
$10.3B
| $13.1M | 3.09% |
71,772
+6,000
| +9% | +$1.16M |
|
|
6
Illumina
ILMN
$28.3B
| $12.4M | 2.93% |
94,767
-14,000
| -13% | -$1.73M |
|
7
Zentalis Pharmaceuticals
ZNTL
$340M
| $11.4M | 2.71% |
3,108,095
+37,653
| +1% | +$137K |
|
8
BeyondSpring
BYSI
$52.2M
| $11.4M | 2.69% |
4,958,143
| – | – |
|
|
9
NewAmsterdam Pharma
NAMS
$3.74B
| $9.79M | 2.32% |
590,000
+190,000
| +48% | +$3.29M |
|
|
MRUS
10
DELISTED
Merus
MRUS
| $9.45M | 2.24% |
189,098
+10,000
| +6% | +$522K |
|
11
MoonLake Immunotherapeutics
MLTX
$1.67B
| $8.4M | 1.99% |
166,600
| – | – |
|
12
Crinetics Pharmaceuticals
CRNX
$8.88B
| $8.07M | 1.91% |
157,958
| – | – |
|
13
Legend Biotech
LEGN
$4.46B
| $5.29M | 1.25% |
108,558
+10,000
| +10% | +$533K |
|
14
Cytokinetics
CYTK
$11.2B
| $4.97M | 1.18% |
94,043
| – | – |
|
15
Aura Biosciences
AURA
$725M
| $4.59M | 1.09% |
515,555
| – | – |
|
16
GeneDx Holdings
WGS
$1.96B
| $4.4M | 1.04% |
103,604
| – | – |
|
17
4D Molecular Therapeutics
FDMT
$611M
| $4.3M | 1.02% |
397,835
+50,000
| +14% | +$830K |
|
18
Equillium
EQ
$166M
| $3.7M | 0.88% |
4,447,308
| – | – |
|
19
Vera Therapeutics
VERA
$3.05B
| $3.08M | 0.73% |
69,767
| – | – |
|
|
LBPH
20
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.88M | 0.44% |
+56,350
| New | +$1.94M |
|
|
ACLX
21
DELISTED
Arcellx
ACLX
| $1.77M | 0.42% |
21,177
+20,000
| +1,699% | +$1.33M |
|
22
Pyxis Oncology
PYXS
$154M
| $1.2M | 0.28% |
326,810
| – | – |
|
23
AtriCure
ATRC
$1.75B
| $751K | 0.18% |
26,797
| – | – |
|
|
GRAL
24
GRAIL Inc
GRAL
$3.19B
| $133K | 0.03% |
9,684
-8,443
| -47% | -$128K |
|
25
Revolution Medicines
RVMD
$39.2B
| $90.7K | 0.02% |
+2,000
| New | +$87.1K |
|
Similar funds
TPM
AWA
FAM
OL
GC
HIG
RCG
AWM